https://pharmadog.xyz/news/482682 pharmadog en 2026-10-01T19:02:08.000Z FDA approves first pediatric heart valve that expands as children grow https://pharmadog.xyz/news/482199 pharmadog en 2026-10-01T18:00:00.000Z Science journal launches special issue on women’s health, spotlighting menopause and chronic pain https://pharmadog.xyz/news/482031 pharmadog en 2026-10-01T16:31:11.000Z Podcast examines growing US mistrust in science and a new gene-editing lawsuit https://pharmadog.xyz/news/482051 pharmadog en 2026-10-01T16:16:00.000Z Eli Lilly, Novo, AbbVie and Boehringer showcase new obesity drug data at European meeting https://pharmadog.xyz/news/482032 pharmadog en 2026-10-01T16:15:16.000Z CDC plans to drop disability questions from health survey, sparking concerns of undercounting https://pharmadog.xyz/news/481883 pharmadog en 2026-10-01T15:38:00.000Z Sanofi, Regeneron expand partnership with $1 billion deal to develop next-generation Dupixent-like antibodies https://pharmadog.xyz/news/481819 pharmadog en 2026-10-01T15:29:31.000Z United Therapeutics wins Delaware court case; BMS secures pediatric approval for Camzyos https://pharmadog.xyz/news/481820 pharmadog en 2026-10-01T15:26:25.000Z Study finds AI may be driving up healthcare costs https://pharmadog.xyz/news/481843 pharmadog en 2026-10-01T15:24:10.000Z Merck’s antibody impresses with ‘highly competitive’ data in chronic skin disease https://pharmadog.xyz/news/481863 pharmadog en 2026-10-01T15:22:13.000Z Reporter visits Shanghai to see China’s fast‑growing biotech sector as Chinese‑designed drugs make up about half of the global pipeline https://pharmadog.xyz/news/482053 pharmadog en 2026-10-01T15:06:05.000Z HHS launches funding programs to accelerate U.S. clinical trials amid rising Chinese competition https://pharmadog.xyz/news/481844 pharmadog en 2026-10-01T14:57:42.000Z BMS flags liver injury cases, including a death, in Phase 3 trial of pulmonary fibrosis drug admilparant https://pharmadog.xyz/news/481845 pharmadog en 2026-10-01T14:51:11.000Z Foghorn Therapeutics cuts 40% of workforce after ending Lilly oncology partnership https://pharmadog.xyz/news/481675 pharmadog en 2026-10-01T14:42:09.000Z FDA issues warning letter to Fresenius Kabi over famotidine injection contamination https://pharmadog.xyz/news/481676 pharmadog en 2026-10-01T14:32:39.000Z Zealand Pharma shares fall as Boehringer Ingelheim partnership weight-loss drug shows modest 9.8% loss in Phase 3 https://pharmadog.xyz/news/481543 pharmadog en 2026-10-01T14:14:59.000Z Eli Lilly ends partnership with Foghorn Therapeutics, prompting 40% staff cut at biotech https://pharmadog.xyz/news/481567 pharmadog en 2026-10-01T14:12:07.000Z US government unveils AI-driven SURPASS program to accelerate clinical trials https://pharmadog.xyz/news/481587 pharmadog en 2026-10-01T14:02:51.000Z Blue Shield of California plans to adopt Medicare-inspired chronic-care payment model by 2027 https://pharmadog.xyz/news/481375 pharmadog en 2026-10-01T13:42:19.000Z Regeneron antibody restores muscle loss in patients after stopping Wegovy, mid-stage data show https://pharmadog.xyz/news/481376 pharmadog en 2026-10-01T13:35:23.000Z Anthropic AI reports first scientific discovery: new enzyme system https://pharmadog.xyz/news/481419 pharmadog en 2026-10-01T13:26:58.000Z Final Medicare rule to curb doctor-administered drug prices covers only four firms, delivering far less savings than proposed https://pharmadog.xyz/news/90022 pharmadog en 2026-10-01T13:04:00.000Z Upcoming FDA decisions in Q3 2026 could signal agency flexibility https://pharmadog.xyz/news/481377 pharmadog en 2026-10-01T13:00:54.000Z Parakeet Health secures $10 million to expand AI-driven patient outreach platform https://pharmadog.xyz/news/481378 pharmadog en 2026-10-01T13:00:20.000Z Devoted Health secures $1.2 billion in new funding to fuel senior member growth https://pharmadog.xyz/news/481232 pharmadog en 2026-10-01T12:42:57.000Z Vertex completes $10 billion Crinetics acquisition as Q3 M&A slows https://pharmadog.xyz/news/481083 pharmadog en 2026-10-01T11:50:22.000Z Trump administration appeals court decision that blocks limits on international student and postdoc visas https://pharmadog.xyz/news/481039 pharmadog en 2026-10-01T11:00:48.000Z Kallyope rebrands as TriGemX Bio, secures $94M to fund Phase 3 migraine trial https://pharmadog.xyz/news/481040 pharmadog en 2026-10-01T11:00:44.000Z House lawmakers hear mixed views on credentialing for psychedelic providers https://pharmadog.xyz/news/480895 pharmadog en 2026-10-01T10:39:40.000Z FAIR Act could boost U.S. rare‑disease trial access and restore biotech leadership https://pharmadog.xyz/news/480916 pharmadog en 2026-10-01T10:30:00.000Z UniQure’s Huntington’s gene therapy shows reduced benefit in fourth year, but patient remains optimistic https://pharmadog.xyz/news/480915 pharmadog en 2026-10-01T10:30:00.000Z Invivyd reports Phase 3 LIBERTY trial shows its low-dose antibody VYD2311 is safer and better tolerated than Pfizer’s Covid vaccine https://pharmadog.xyz/news/481627 pharmadog en 2026-10-01T10:24:00.000Z BMS trial sees patient death, analysts say drug mechanism still viable https://pharmadog.xyz/news/480703 pharmadog en 2026-10-01T09:53:38.000Z Sanofi to pay $1 billion upfront to expand antibody partnership with Regeneron https://pharmadog.xyz/news/481350 pharmadog en 2026-10-01T09:37:00.000Z Roche Diagnostics unveils single-assay newborn test for SMA, SCID and Sickle Cell Disease https://pharmadog.xyz/news/481352 pharmadog en 2026-10-01T08:37:00.000Z Foghorn Therapeutics cuts 40% of staff after Lilly partnership ends over weak phase-1 data https://pharmadog.xyz/news/480581 pharmadog en 2026-10-01T08:30:00.000Z Senate finance and health committees brace for major Republican turnover ahead of midterms https://pharmadog.xyz/news/480579 pharmadog en 2026-10-01T08:30:00.000Z Chinese biotech firms showcase rapid drug development at Shanghai Science City conference https://pharmadog.xyz/news/480580 pharmadog en 2026-10-01T08:30:00.000Z Former GOP leader Eric Cantor appointed to steer PhRMA amid bipartisan concerns over drug costs https://pharmadog.xyz/news/480583 pharmadog en 2026-10-01T08:30:00.000Z AI system Claude decodes a whole genome in 30 minutes, sparking call for result standards https://pharmadog.xyz/news/480582 pharmadog en 2026-10-01T08:30:00.000Z Study finds GLP-1 weight-loss drugs appear safe and effective for children with severe obesity https://pharmadog.xyz/news/480367 pharmadog en 2026-10-01T07:30:26.000Z Boehringer's obesity drug shows up to 9.8% weight loss in diabetes patients but lags behind competitors https://pharmadog.xyz/news/480135 pharmadog en 2026-10-01T06:16:27.000Z Sanofi and Regeneron deepen collaboration, adding new immunology antibody program https://pharmadog.xyz/news/480846 pharmadog en 2026-10-01T06:15:00.000Z Zealand Pharma shares tumble 12% after Boehringer obesity drug trial meets endpoints but disappoints analysts https://pharmadog.xyz/news/480678 pharmadog en 2026-10-01T04:24:00.000Z Sanofi pays Regeneron $1 billion upfront to co-develop four early-stage immunology assets https://pharmadog.xyz/news/197927 pharmadog en 2026-10-01T04:01:00.000Z BioSpace lists top 12 biopharma employers hiring in July 2026 https://pharmadog.xyz/news/479799 pharmadog en 2026-10-01T04:01:00.000Z Biopharma job seekers urged to act quickly in Q4 hiring surge https://pharmadog.xyz/news/478871 pharmadog en 2026-09-30T23:15:09.000Z Trump administration's final Medicare pricing rule limits savings, covering only four firms https://pharmadog.xyz/news/478703 pharmadog en 2026-09-30T22:40:54.000Z UnitedHealth lawsuit proceeds as judge rejects motion to dismiss earnings manipulation claims https://pharmadog.xyz/news/478659 pharmadog en 2026-09-30T22:01:26.000Z CMS finalizes GLOBE Medicare drug price demo, projected savings cut to $440 million https://pharmadog.xyz/news/478259 pharmadog en 2026-09-30T20:09:15.000Z HHS launches SURPASS program to accelerate clinical trials using AI and adaptive designs https://pharmadog.xyz/news/477879 pharmadog en 2026-09-30T18:41:34.000Z Patient death raises safety concerns before Bristol Myers lung drug readout https://pharmadog.xyz/news/477711 pharmadog en 2026-09-30T17:30:54.000Z American Biotech Innovation Alliance urges Congress to prioritize US leadership in biopharma https://pharmadog.xyz/news/477499 pharmadog en 2026-09-30T16:22:00.000Z Bristol Myers revises Phase 3 fibrosis trial after liver safety events, including a death https://pharmadog.xyz/news/477500 pharmadog en 2026-09-30T15:54:00.000Z FDA begins review of Roche’s experimental multiple sclerosis pill fenebrutinib https://pharmadog.xyz/news/477311 pharmadog en 2026-09-30T15:50:06.000Z U.S. plan to cut Medicaid for legal immigrants, including refugees and trafficking victims, takes effect Oct. 1 https://pharmadog.xyz/news/477267 pharmadog en 2026-09-30T15:35:41.000Z Varda Space Industries secures $251 million Series D to develop drug manufacturing in orbit https://pharmadog.xyz/news/477268 pharmadog en 2026-09-30T15:32:50.000Z AbbVie’s eczema antibody shows statistically significant benefit in Phase 2 trial https://pharmadog.xyz/news/477123 pharmadog en 2026-09-30T14:52:33.000Z Atara and Pierre Fabre resubmit Ebvallo cell therapy after second FDA rejection https://pharmadog.xyz/news/477124 pharmadog en 2026-09-30T14:52:03.000Z Massachusetts offers $40M in tax incentives to spur 1,600+ life-science jobs https://pharmadog.xyz/news/477143 pharmadog en 2026-09-30T14:37:55.000Z STAT releases AI Prognosis newsletter on health tech leaders' policy discussions in Washington https://pharmadog.xyz/news/477163 pharmadog en 2026-09-30T14:18:00.000Z PhRMA appoints former congressman Eric Cantor as CEO as Pierre Fabre resubmits Ebvallo approval request https://pharmadog.xyz/news/477125 pharmadog en 2026-09-30T14:16:00.000Z Lilly’s EloraTZP combo shows superior weight loss and glucose control, moves to Phase 3 https://pharmadog.xyz/news/477144 pharmadog en 2026-09-30T14:15:00.000Z Eli Lilly’s Zepbound plus amylin candidate shows 23% weight loss in phase 2 trial, but many patients stopped treatment https://pharmadog.xyz/news/477145 pharmadog en 2026-09-30T14:12:49.000Z Poll finds most rural MAHA supporters say Trump health policies have not improved community health https://pharmadog.xyz/news/476975 pharmadog en 2026-09-30T13:39:27.000Z Beam sues over alleged IP theft as Moderna appoints new COO and Pierre Fabre/Atara refile drug for ultra-rare blood cancer https://pharmadog.xyz/news/476976 pharmadog en 2026-09-30T13:35:50.000Z Beam Therapeutics files lawsuit accusing former scientist of stealing IP to launch Chinese biotech venture https://pharmadog.xyz/news/477626 pharmadog en 2026-09-30T13:26:33.000Z FDA launches nationwide recruitment to broaden scientific and consumer representation on advisory committees https://pharmadog.xyz/news/476955 pharmadog en 2026-09-30T13:06:35.000Z Lilly uses indirect data to argue its oral GLP-1 pill may outperform Novo’s semaglutide https://pharmadog.xyz/news/476787 pharmadog en 2026-09-30T12:36:54.000Z BioNTech to shut three German manufacturing sites after failing to secure buyers, risking 1,860 jobs https://pharmadog.xyz/news/477686 pharmadog en 2026-09-30T12:27:00.000Z Lilly's amylin-Zepbound combo shows 23% weight loss in type 2 diabetes patients https://pharmadog.xyz/news/476639 pharmadog en 2026-09-30T11:59:12.000Z Pennsylvania reports four measles deaths this year, CDC records only two https://pharmadog.xyz/news/134233 pharmadog en 2026-09-30T11:39:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/123087 pharmadog en 2026-09-30T11:31:00.000Z BioSpace launches dashboard to track performance of U.S. biotech IPOs in 2026 https://pharmadog.xyz/news/476487 pharmadog en 2026-09-30T11:07:16.000Z Ned Sharpless joins Hatteras Venture Partners as managing director, Andrew Witty returns as chairman https://pharmadog.xyz/news/477242 pharmadog en 2026-09-30T10:44:00.000Z Beam Therapeutics sues rival YolTech over alleged theft of base-editing data for AATD therapy https://pharmadog.xyz/news/477074 pharmadog en 2026-09-30T10:23:00.000Z Merck reports positive phase 2b results for anti-TL1A antibody in hidradenitis suppurativa https://pharmadog.xyz/news/476343 pharmadog en 2026-09-30T10:07:52.000Z AstraZeneca invests $2 billion in Summit Therapeutics as uniQure shares tumble on disappointing Huntington’s data https://pharmadog.xyz/news/476907 pharmadog en 2026-09-30T09:20:00.000Z GSK pays $12 million to Wave for liver-focused siRNA program, expanding its RNA drug pipeline https://pharmadog.xyz/news/476909 pharmadog en 2026-09-30T08:55:00.000Z Connect Biopharma's IL-4/IL-13 blocker cuts COPD exacerbations by 85% in Phase 2 trial https://pharmadog.xyz/news/476028 pharmadog en 2026-09-30T08:30:00.000Z Experts call for regulation of kratom and potent 7-OH products, debate over specific rules https://pharmadog.xyz/news/476027 pharmadog en 2026-09-30T08:30:00.000Z US must strengthen its biotech sector to stay ahead of China, authors argue https://pharmadog.xyz/news/476029 pharmadog en 2026-09-30T08:30:00.000Z Researchers create mouse with human-derived brain cortex, sparking ethical and scientific debate https://pharmadog.xyz/news/476738 pharmadog en 2026-09-30T08:18:00.000Z VertigoDx receives FDA 510(k) clearance for its portable SmartVertigo diagnostic system https://pharmadog.xyz/news/475371 pharmadog en 2026-09-30T05:00:30.000Z Merck reports positive mid-stage results for Prometheus' tulisokibart in painful skin disease https://pharmadog.xyz/news/476126 pharmadog en 2026-09-30T04:57:00.000Z Mid-dose petrelintide shows strongest weight loss in phase-2 trial, paving way for pivotal study https://pharmadog.xyz/news/476127 pharmadog en 2026-09-30T04:27:00.000Z Amgen's daxdilimab shows 6-point CLASI-A reduction in phase 2 lupus trial https://pharmadog.xyz/news/475228 pharmadog en 2026-09-30T04:02:00.000Z Women-led biotech M&A drops sharply in 2026, only two major deals recorded so far https://pharmadog.xyz/news/475227 pharmadog en 2026-09-30T04:02:00.000Z Bicara CEO Claire Mazumdar to step down, COO Ryan Cohlhepp to assume leadership in 2027 https://pharmadog.xyz/news/475229 pharmadog en 2026-09-30T04:01:00.000Z Biopharma must incentivize scientists to make early go-no-go decisions https://pharmadog.xyz/news/475790 pharmadog en 2026-09-30T03:06:00.000Z Eli Lilly's retatrutide shows over a third of patients lose 25%+ weight in phase 3 trial https://pharmadog.xyz/news/478733 pharmadog en 2026-09-30T00:00:00.000Z FDA seeks new advisory committee members, signaling renewed focus on external expertise https://pharmadog.xyz/news/478734 pharmadog en 2026-09-30T00:00:00.000Z Industry groups back FDA draft guidance on single‑trial approvals but seek clearer flexibility rules https://pharmadog.xyz/news/474131 pharmadog en 2026-09-29T22:46:45.000Z MAHA Summit Shows Grassroots Health Movement Aligning with Industry Leaders https://pharmadog.xyz/news/474087 pharmadog en 2026-09-29T22:01:52.000Z Zealand and Roche's amylin analog shows modest weight loss at middle dose, lagging behind Lilly's in Phase 2 trial https://pharmadog.xyz/news/474088 pharmadog en 2026-09-29T22:01:10.000Z Lilly's triple-agonist retatrutide drives up to 18.8% weight loss, over half of patients fall below obesity threshold